Barriers to Oncology Biosimilars Uptake in the United States

Biosimilars are biological compounds that contain an active substance that is similar to the active substance in an already approved biologic. This commentary focuses on the barriers to the use of biosimilars in the United States.

Detalles Bibliográficos
Autores principales: Nabhan, Chadi, Valley, Amy, Feinberg, Bruce A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2018
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291332/
https://www.ncbi.nlm.nih.gov/pubmed/30049886
http://dx.doi.org/10.1634/theoncologist.2018-0066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291332/
https://www.ncbi.nlm.nih.gov/pubmed/30049886
http://dx.doi.org/10.1634/theoncologist.2018-0066

Ejemplares similares